AQR Capital Management’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-40,797
| Closed | -$2.77M | – | 2237 |
|
|
2019
Q3 | $2.77M | Sell |
40,797
-351,909
| -90% | -$24.2M | ﹤0.01% | 1167 |
|
|
2019
Q2 | $22.8M | Buy |
392,706
+16,545
| +4% | +$980K | 0.03% | 561 |
|
|
2019
Q1 | $26.4M | Sell |
376,161
-46,456
| -11% | -$3.44M | 0.03% | 544 |
|
|
2018
Q4 | $27.2M | Buy |
422,617
+142,190
| +51% | +$9.97M | 0.03% | 494 |
|
|
2018
Q3 | $19.7M | Buy |
280,427
+107,094
| +62% | +$6.26M | 0.02% | 587 |
|
|
2018
Q2 | $8.74M | Buy |
173,333
+25,110
| +17% | +$996K | 0.01% | 831 |
|
|
2018
Q1 | $4.64M | Buy |
148,223
+6,868
| +5% | +$228K | 0.01% | 1029 |
|
|
2017
Q4 | $4.83M | Buy |
141,355
+28,639
| +25% | +$913K | 0.01% | 1045 |
|
|
2017
Q3 | $3.62M | Buy |
112,716
+46,824
| +71% | +$1.48M | ﹤0.01% | 1158 |
|
|
2017
Q2 | $2.15M | Buy |
65,892
+39,126
| +146% | +$1.24M | ﹤0.01% | 1355 |
|
|
2017
Q1 | $843K | Buy |
26,766
+8,563
| +47% | +$253K | ﹤0.01% | 1733 |
|
|
2016
Q4 | $535K | Sell |
18,203
-5,282
| -22% | -$161K | ﹤0.01% | 1908 |
|
|
2016
Q3 | $679K | Buy |
23,485
+13,062
| +125% | +$364K | ﹤0.01% | 1853 |
|
|
2016
Q2 | $270K | Buy |
+10,423
| New | +$277K | ﹤0.01% | 2040 |
|
|
2016
Q1 | – | Sell |
-19,489
| Closed | -$686K | – | 2324 |
|
|
2015
Q4 | $686K | Buy |
+19,489
| New | +$522K | ﹤0.01% | 1736 |
|
AQR Capital Management's GHDX Position: Q4 2019 in Review
AQR Capital Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 40,797 shares — an estimated $2.77M sold.
AQR Capital Management first reported a position in GHDX in Q4 2015 and held it in 15 quarters. The position peaked at $27.2M in Q4 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- AQR Capital Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- AQR Capital Management sold 40,797 Genomic Health, Inc. shares in Q4 2019, an estimated $2.77M.
- AQR Capital Management first reported a position in Genomic Health, Inc. in Q4 2015 and held it in 15 quarters.
- AQR Capital Management's Genomic Health, Inc. position peaked at $27.2M in Q4 2018.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on AQR Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.